Point72 Middle East Fze’s Abbott Laboratories Position
Does Point72 Middle East Fze own Abbott Laboratories (ABT)? Not currently — the last reported position was 239.2K shares worth $23M in Q3 2023; the fund’s latest 13F (Q3 2025) no longer reports it.
Position Value
$23M
Q3 2023
Shares
239.2K
% of Portfolio
+0.76%
Quarters Held
2
position exited
Position History ABT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Point72 Middle East Fze’s full portfolio or all institutional holders of ABT.